>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Comment Letter on 2012 CMS Physician Fee Schedule Proposed Rule

Tuesday, August 30, 2011

In mid-July, the Centers for Medicare & Medicaid Services (CMS) issued a Notice of Proposed Rule Making (NPRM) seeking comment on a proposed ruled that addressed changes to the “Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to part B for CY 2012.”  

ASA offered comments on a number of areas impacting anesthesiology:

-Improvements to the physician feedback program and establishment of the value-based payment modifier program
-Potentially misvalued services under the physician fee schedule
-Code specific issues including site of service anomalies, Epidural Lysis, Intrathecal Epidural Catheters and Pumps and Neurostimulators
-Physician Quality Reporting System (PQRS)
-Anesthesia Conversion Factor
-Electronic Prescribing (eRx) Incentive Program
-Medicare Telehealth Services for the Physician Fee Schedule

Read the comments ASA submitted to CMS.


 

« Back to Washington Alerts